Demonstration of differential virulence gene promoter activation in vivo in Bordetella pertussis using RIVET
Open Access
- 25 November 2004
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 55 (3) , 788-798
- https://doi.org/10.1111/j.1365-2958.2004.04418.x
Abstract
Bordetella pertussis, the etiologic agent of whooping cough, causes disease by employing an array of virulence factors controlled by the BvgA-BvgS two-component signal transduction system. Regulation by this system has been extensively characterized in vitro, where bvg-activated genes are repressed in a process known as phenotypic modulation. Differential regulation of these genes by the response regulator BvgA results in promoters that are activated early, middle, or late after being released from modulation. However, the in vivo environmental signal and regulation pattern has not been described. In order to investigate BvgAS-mediated regulation of B. pertussis virulence factors in vivo using the mouse aerosol challenge model, we have adapted the recombinase-based in vivo technology (RIVET) system for use in B. pertussis. We have demonstrated that these strains show resolution during in vitro growth under non-modulating conditions. In addition, we have demonstrated that modulating strains by growth on media containing MgSO4 does not affect virulence in the mouse aerosol challenge model. We have therefore used the RIVET system to reveal the time-course of gene expression in vivo for selected B. pertussis virulence factors (cya, fha, prn and ptx). Our data indicate that this method can be effectively used to monitor and compare in vivo and in vitro gene expression in B. pertussis, and that temporal regulation patterns previously observed in vitro are mirrored in vivo.Keywords
This publication has 58 references indexed in Scilit:
- Pertussis Toxin Plays an Early Role in Respiratory Tract Colonization byBordetella pertussisInfection and Immunity, 2003
- Crucial Role of Antibodies to Pertactin inBordetella pertussisImmunityThe Journal of Infectious Diseases, 2003
- Bordetella pertussis Autoregulates Pertussis Toxin Production through the Metabolism of CysteineInfection and Immunity, 2001
- Role of ADP-Ribosyltransferase Activity of Pertussis Toxin in Toxin-Adhesin Redundancy with Filamentous Hemagglutinin duringBordetella pertussisInfectionInfection and Immunity, 2001
- Differential Regulation of Bvg-Activated Virulence Factors Plays a Role in Bordetella pertussis PathogenicityInfection and Immunity, 2001
- Early colonization of the rat upper respiratory tract by temperature modulatedBordetella bronchisepticaFEMS Microbiology Letters, 1999
- Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.The Journal of Experimental Medicine, 1989
- Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component systemNature, 1989
- Pertussis Toxin and Extracytoplasmic Adenylate Cyclase as Virulence Factors of Bordetella pertussisThe Journal of Infectious Diseases, 1984
- Antigenic modulation ofBordetella pertussisEpidemiology and Infection, 1960